History of rockets Timeline Targeted therapy helps treat deadly childhood neurological cancer The Lancet: Russian COVID-19 vaccine Phase 3 clinical trial interim results released Small molecule drug ...

Earlier this year, they released that data as training fodder in a competition aimed at determining whether any AI models for predicting small molecule interactions with proteins were really ...

The IRA is already leading to significant negative impact on the development of new small molecule medications, with some manufacturers shuttering small molecule development initiatives in favor ...

But as it currently stands, the IRA is driving investors to favor investment in biologics over small molecule treatments. The IRA is already leading to significant negative impact on the development ...

Assembly Bio to receive approximately $20.1 million equity investment and $10 million in accelerated funding under the collaboration, extending ...

This NDA submission marks a pivotal moment for Chimerix in our mission to bring this potentially life-altering drug to patients diagnosed with recurrent H3 K27M-mutant diffuse glioma,” said Mike ...

Gilead Sciences, Inc. (Nasdaq: GILD) and Terray Therapeutics, Inc. announced today that the companies have entered into a strategic collaboration to discover and develop novel, small molecule ...

Ofer Haviv is the CEO and President of Evogene. Prior to this role, he served as the company’s COO and CFO from 2002 to 2004 ...

Oncology Medicinal Chemistry Worldwide Research and Development, Pfizer, Inc., 10770 Science Center Drive, La Jolla, California 92121, United States ...